IBO

NYSE AMEX LISTED TEST STOCK FOR CTS CQS (IBO)

Healthcare • AMEX$0.63+0.30%

Key Fundamentals
Symbol
IBO
Exchange
AMEX
Sector
Healthcare
Industry
Biotechnology
Price
$0.63
Daily Change
+0.30%
Market Cap
$67.82M
Trailing P/E
N/A
Forward P/E
N/A
52W High
$1.95
52W Low
$0.36
Analyst Target
N/A
Dividend Yield
N/A
Beta
N/A
About NYSE AMEX LISTED TEST STOCK FOR CTS CQS

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive i

Company website

Research IBO on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Terms · Privacy · ·

Loading...